Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment

Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment

Saved in:
Bibliographic Details
Main Authors: Jonathan I. Silverberg, Andreas Wollenberg, Linda Stein Gold, James Del Rosso, Gil Yosipovitch, Peter Lio, Jose-Manuel Carrascosa, Gaia Gallo, Yuxin Ding, Zhenhui Xu, Marta Casillas, Evangeline Pierce, Helena Agell, Sonja Ständer
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-10-01
Series:Dermatology and Therapy
Online Access:https://doi.org/10.1007/s13555-024-01269-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items